Scientists in Sweden are working on a shot to ease the craving for a smoke. A vaccine to curb nicotine addiction is currently in the trial stage.
Researchers say the vaccine eliminates the quick high smokers relish and developers believe that once the high is gone so is the cause of the addiction to nicotine.
The drug's manufacturer hopes to have it on the market in two to three years.